Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Dario A.A. Vignali, Ashwin Somasundaram et al.|Science Translational Medicine|2021Cited by 38
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L. Ferris, Julie E. Bauman, Jessica Moskovitz et al.|Clinical Cancer Research|2022Cited by 32